See more : The Green Organic Dutchman Holdings Ltd. (GRODF) Income Statement Analysis – Financial Results
Complete financial analysis of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jagsonpal Pharmaceuticals Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- CAI International, Inc. (CAI) Income Statement Analysis – Financial Results
- BIM Birlesik Magazalar A.S. (BIMAS.IS) Income Statement Analysis – Financial Results
- Kingkey Financial International (Holdings) Limited (1468.HK) Income Statement Analysis – Financial Results
- Nonthavej Hospital Public Company Limited (NTV.BK) Income Statement Analysis – Financial Results
- Japan Smaller Capitalization Fund, Inc. (JOF) Income Statement Analysis – Financial Results
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jagsonpal.com
About Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited engages in the manufacture and trading of pharmaceutical products and active pharmaceutical ingredients in the areas in the areas of women health, pain and analgesics, and general medicine in India and internationally. It offers pharmaceutical formulations and over the counter drugs in the areas of gynaecology, orthopaedics, and allergy management. It offers drugs in the form of tablets, softgels, injections, capsules, and syrups. The company was incorporated in 1978 and is headquartered in New Delhi, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.09B | 2.37B | 2.18B | 1.88B | 1.59B | 1.67B | 1.27B | 1.44B | 1.43B | 1.38B | 1.44B | 1.66B | 1.77B | 1.61B | 1.40B | 1.36B | 1.50B |
| Cost of Revenue | 805.48M | 932.72M | 892.82M | 809.34M | 562.52M | 729.32M | 612.95M | 593.24M | 591.23M | 686.83M | 647.06M | 861.62M | 845.46M | 830.00M | 755.02M | 789.03M | 913.06M |
| Gross Profit | 1.28B | 1.43B | 1.28B | 1.07B | 1.02B | 938.94M | 652.38M | 845.47M | 843.65M | 694.68M | 791.45M | 803.02M | 919.68M | 779.55M | 640.91M | 572.94M | 587.88M |
| Gross Profit Ratio | 61.41% | 60.60% | 58.97% | 56.94% | 64.53% | 56.28% | 51.56% | 58.77% | 58.80% | 50.28% | 55.02% | 48.24% | 52.10% | 48.43% | 45.91% | 42.07% | 39.17% |
| Research & Development | 0.00 | 0.00 | 0.00 | 3.46M | 1.54M | 1.21M | 3.74M | 5.64M | 4.69M | 3.29M | 5.55M | 6.93M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 634.83M | 57.64M | 101.73M | 42.72M | 27.00M | 14.97M | 6.93M | 6.35M | 93.72M | 87.07M | 452.00K | 400.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 163.36M | 186.08M | 138.79M | 129.90M | 174.55M | 131.98M | 112.46M | 137.44M | 109.96M | 75.41M | 38.55M | 38.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 773.41M | 243.72M | 240.52M | 172.62M | 201.55M | 146.94M | 119.39M | 143.79M | 203.67M | 162.48M | 604.96M | 615.01M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 11.13M | 1.74M | 3.57M | 3.74M | 1.32M | 1.20M | 3.43M | 1.00K | 0.00 | 15.00K | 2.91M | 3.21M | 2.28M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 773.41M | 1.10B | 1.04B | 882.25M | 949.13M | 854.42M | 765.45M | 804.30M | 750.56M | 633.51M | 712.32M | 729.56M | 778.89M | 656.25M | 500.95M | 428.17M | 472.45M |
| Cost & Expenses | 1.58B | 2.03B | 1.93B | 1.69B | 1.51B | 1.58B | 1.38B | 1.40B | 1.34B | 1.32B | 1.36B | 1.59B | 1.62B | 1.49B | 1.26B | 1.22B | 1.39B |
| Interest Income | 85.92M | 34.28M | 15.46M | 29.92M | 21.68M | 12.97M | 3.36M | 1.26M | 634.00K | 131.00K | 592.00K | 319.00K | 475.00K | 325.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 8.14M | 2.78M | 2.61M | 4.28M | 3.83M | 4.44M | 5.00M | 24.71M | 51.07M | 41.27M | 53.82M | 51.34M | 43.58M | 33.22M | 34.96M | 45.79M | 63.51M |
| Depreciation & Amortization | 16.63M | 11.75M | 15.26M | 10.86M | 11.30M | 10.16M | 3.20M | 19.94M | 30.94M | 27.07M | 28.25M | 27.08M | 25.36M | 22.01M | 20.85M | 12.50M | 16.87M |
| EBITDA | 323.46M | 363.96M | 255.13M | 198.72M | 85.33M | 93.35M | -100.64M | 59.63M | 124.02M | 88.24M | 107.39M | 103.77M | 169.84M | 145.31M | 160.81M | 153.64M | 128.62M |
| EBITDA Ratio | 15.50% | 16.94% | 13.28% | 12.31% | 6.90% | 6.27% | -7.95% | 4.21% | 8.56% | 6.16% | 7.47% | 6.04% | 9.41% | 9.03% | 11.52% | 11.55% | 8.81% |
| Operating Income | 508.13M | 342.07M | 246.17M | 180.16M | 74.84M | 83.25M | -114.10M | 143.97M | 40.75M | 16.72M | 25.30M | 22.45M | 97.69M | 92.68M | 105.00M | 98.99M | 51.92M |
| Operating Income Ratio | 24.35% | 14.45% | 11.31% | 9.59% | 4.72% | 4.99% | -9.02% | 10.01% | 2.84% | 1.21% | 1.76% | 1.35% | 5.53% | 5.76% | 7.52% | 7.27% | 3.46% |
| Total Other Income/Expenses | -209.44M | -272.05M | -308.38M | -186.18M | -236.34M | -359.60M | -2.17M | -267.57M | -387.01M | -43.48M | -117.61M | -48.18M | -40.04M | -30.62M | -31.33M | -39.45M | -57.28M |
| Income Before Tax | 298.69M | 348.08M | 266.42M | 218.72M | 94.15M | 90.03M | -116.27M | 143.97M | 40.75M | 16.72M | 25.31M | 25.36M | 100.90M | 92.68M | 105.00M | 98.99M | 51.92M |
| Income Before Tax Ratio | 14.31% | 14.70% | 12.24% | 11.64% | 5.94% | 5.40% | -9.19% | 10.01% | 2.84% | 1.21% | 1.76% | 1.52% | 5.72% | 5.76% | 7.52% | 7.27% | 3.46% |
| Income Tax Expense | 74.06M | 80.87M | 77.87M | 48.14M | 15.44M | 17.87M | -761.00K | 25.32M | 8.21M | 5.01M | 4.11M | 7.04M | 26.33M | 20.89M | 12.58M | 37.26M | 21.16M |
| Net Income | 224.63M | 267.21M | 188.55M | 170.58M | 78.71M | 72.16M | -115.51M | 118.65M | 32.54M | 11.71M | 21.21M | 18.33M | 74.57M | 71.80M | 92.42M | 61.72M | 30.76M |
| Net Income Ratio | 10.76% | 11.29% | 8.67% | 9.08% | 4.96% | 4.33% | -9.13% | 8.25% | 2.27% | 0.85% | 1.47% | 1.10% | 4.22% | 4.46% | 6.62% | 4.53% | 2.05% |
| EPS | 8.49 | 10.20 | 7.20 | 6.51 | 3.00 | 2.75 | -4.41 | 4.53 | 1.24 | 0.45 | 0.81 | 0.70 | 2.85 | 2.74 | 3.76 | 2.35 | 1.17 |
| EPS Diluted | 8.46 | 10.20 | 7.20 | 6.51 | 3.00 | 2.75 | -4.41 | 4.53 | 1.24 | 0.45 | 0.81 | 0.70 | 2.85 | 2.74 | 3.76 | 2.35 | 1.17 |
| Weighted Avg Shares Out | 26.45M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.18M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M |
| Weighted Avg Shares Out (Dil) | 26.55M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.18M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M | 26.20M |
Source: https://incomestatements.info
Category: Stock Reports